Centrient Pharmaceuticals announces its achievement of a significant milestone in the clean production of antibiotics

Being the first company to publicly announce 100% PNEC compliance for its entire oral antibiotics product range Rijswijk, The Netherlands, May 19, 2022 (GLOBE NEWSWIRE) — Summary Centrient Pharmaceuticals reached a significant milestone in the clean production of its antibiotics, with the lowest environmental impact and minimizing the potential contribution to antimicrobial resistance The company […]

Advance Local is New Sophi.io Customer

TORONTO, May 18, 2022 (GLOBE NEWSWIRE) — Advance Local, one of the largest media groups in the United States operating 10 leading news and information organizations and reaching 55 million people monthly, has quadrupled their subscription goal using Sophi Content Paywall Engine. Faced with advertising pressures exacerbated by the Coronavirus, Advance Local increased subscription conversions […]

TripleBlind Appoints Encryption, Privacy and Blockchain Expert Craig Gentry as Chief Technology Officer

KANSAS CITY, Mo., May 18, 2022 (GLOBE NEWSWIRE) — TripleBlind, creator of the most complete and scalable solution for privacy enhancing computation, announces Craig Gentry as the new Chief Technology Officer. Craig will lead TripleBlind’s technology vision for expanding the most comprehensive privacy preserving technology in the industry. Craig joins TripleBlind with more than 20 […]

ECOTONE ANNOUNCES €20 MILLION INVESTMENT TO MEET GROWING DEMAND FOR PLANT-BASED BEVERAGES IN THE EUROPEAN MARKET

18 MAY 2022 ECOTONE ANNOUNCES €20 MILLION INVESTMENT TO MEET GROWING DEMAND FOR PLANT-BASED BEVERAGES IN THE EUROPEAN MARKET Ecotone, a pioneer in organic and plant-based alternatives in France and Europe, has announced a €20 million investment in its plant-based beverage production site located in Badia Polesine, Northern Italy. The major investment has enabled the […]

AGC Biologics Invests in New Viral Vector Suspension Capabilities at U.S. Cell & Gene Hub

New technology and capacity help CDMO’s advanced-therapies campus meet growing market demand SEATTLE, May 17, 2022 (GLOBE NEWSWIRE) — AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it is adding viral vector suspension technology and capacity for the development and manufacturing of gene therapies at its commercial-grade campus in […]